Welcome to the 2021 Targeted Therapies of Lung Cancer Meeting | Worldwide Virtual Event! The virtual platform is now open and will stay open until April 30, 2021.
The IASLC Targeted Therapies of Lung Cancer meeting is a dynamic meeting with a long tradition. And while this is the first time it will be delivered as a virtual event, we are looking forward to more than 600 participants to share information about ongoing clinical trials of the newest therapies for lung cancer. Meeting presenters will summarize the data on relevant targets for new therapies and share data on preclinical and early clinical data for each of the drugs directed against these targets. All sessions will include an extended Live Q&A with presenters and world-renowned panelists.
We welcome you once again and hope you will enjoy the very first TTLC Virtual Meeting.